Sutro Biopharma, Inc.STRONASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank13
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
-167.09%
↑ 20% vs avg
Percentile
P13
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-209.89%
Historical baseline
PeriodValue
2024-167.09%
202330.76%
2022-30.87%
2021-38.65%
2020-28.10%
2019-49.02%
2018-93.15%
2017-1512.90%
20160.00%